NAFLD is related with massive release of pro-inflammatory factors, such as interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α) and interleukin-1β (IL-1β) (5). Here, IL1B is linked to metabolic dysfunction-associated steatotic liver disease.